Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry
- 22 December 2016
- journal article
- research article
- Published by Elsevier BV in Lung Cancer
- Vol. 104, 98-105
- https://doi.org/10.1016/j.lungcan.2016.12.017
Abstract
No abstract availableKeywords
Funding Information
- Research Center for Advanced Molecular Medicine, Fukuoka University, Izumo City Supporting Cancer Research Project (ICSCRP)
- Ministry of the Environment
This publication has 38 references indexed in Scilit:
- Primate Genome Gain and Loss: A Bone Dysplasia, Muscular Dystrophy, and Bone Cancer Syndrome Resulting from Mutated Retroviral-Derived MTAP TranscriptsAmerican Journal of Human Genetics, 2012
- The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomasHistopathology, 2012
- CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survivalLaboratory Investigation, 2010
- Immunohistochemical diagnosis of methylthioadenosine phosphorylase (MTAP) deficiency in non-small cell lung carcinomaLung Cancer, 2009
- Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomasVirchows Archiv, 2008
- A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancerInvestigational New Drugs, 2008
- Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomasLaboratory Investigation, 2008
- Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesionLaboratory Investigation, 2005
- A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancerOncogene, 2000
- Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC)Oncogene, 1998